Q4 2024 Earnings Call Transcript March 12, 2025 Assertio Holdings, Inc. misses on earnings expectations. Reported EPS is ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

Assertio (ASRT) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.11 per share a year ago. These figures are ...

In a report released today, Thomas Flaten from Lake Street maintained a Buy rating on Assertio Therapeutics (ASRT – Research Report), with a price target of $3.00. The company’s shares closed ...

Stay updated on market trends for ASRT. Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Asana, Inc. (NYSE: ASAN) fell sharply during ...

Short interest in Assertio Holdings Inc (NASDAQ:ASRT) decreased during the last reporting period, falling from 6.04M to 5.73M. This put 6.07% of the company's publicly available shares short.

Detailed price information for Assertio Therapeutics Inc (ASRT-Q) from The Globe and Mail including charting and trades.

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.